By applying WGCNA to pure CD11b+ transcriptomic datasets, we could recapitulate the spectrum of homeostatic microglia and DAM in AD models, in addition to resolving DAM into anti-inflammatory/phagocytic and pro-inflammatory profiles, thereby providing a framework for validation and therapeutic studies. The gene discussed is ITGAM; the disease is Alzheimer disease.